Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
447.30
|
|
Change (%)
|
-2.40 (-0.53%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
442.15
-
453.70
|
|
52-Week Range (RS)
|
299.30
-
470.90
|
|
Beta (1 Year)
|
0.73
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE Midcap |
| News |
|
Corporate Details |
| Laurus Labs Ltd - Laurus Labs Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
| Laurus Labs Ltd - Laurus Labs Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
| Board of Laurus Labs recommends Second Interim Dividend |
| Laurus Labs fixes record date for 2nd interim dividend |
| Laurus Labs consolidated net profit declines 26.58% in the March 2024 quarter |
| Laurus Lab slides after Q4 PAT tumbles 26% YoY to 76 cr |
| Laurus Labs AGM scheduled |
| Laurus Labs Ltd - Laurus Labs Limited - Dividend |
| Laurus Labs Ltd - Laurus Labs Limited - Record Date |
| Laurus Labs Ltd - Laurus Labs Limited - Change in Director(s) |
|
|
|
| Incoporation Year : 2005 |
| Chairman : M V G Rao |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Laurus Labs Ltd
Plot No 21 Jawaharlal Nehru,
Pharma City Parawada,
Visakhapatnam,
Andhra Pradesh-531021 |
Phone:91-891-3061222
Fax:91-891-3061270 |
| E-Mail : secretarial@lauruslabs.com; info@lauruslabs.com |
| URL : http://www.lauruslabs.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
25-Apr-2024 |
425.30 |
5.74 |
| 1Month |
02-Apr-2024 |
415.15 |
8.32 |
| 3Month |
02-Feb-2024 |
392.20 |
14.66 |
| 6Month |
02-Nov-2023 |
362.15 |
24.18 |
| 1Year |
02-May-2023 |
311.15 |
44.53 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Mirae Asset ELSS Tax Saver Fund |
1.28 |
274.40 |
| Mirae Asset Large & Midcap Fund |
0.60 |
200.43 |
| Mirae Asset Midcap Fund |
1.13 |
161.26 |
| PGIM India Midcap Opportunities Fund |
1.00 |
99.26 |
| SBI Magnum Midcap Fund |
0.57 |
96.13 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceuticals Industries Ltd |
1,508.40 |
-0.66 |
1,638.70 |
922.55 |
361,915.69 |
| Cipla Ltd |
1,424.75 |
0.37 |
1,519.00 |
897.70 |
115,033.60 |
| Dr Reddys Laboratories Ltd |
6,349.95 |
0.98 |
6,505.50 |
4,383.40 |
105,928.76 |
| Zydus Lifesciences Ltd |
997.00 |
0.90 |
1,031.30 |
482.55 |
100,321.53 |
| Mankind Pharma Ltd |
2,314.30 |
-0.85 |
2,488.65 |
1,240.75 |
92,708.18 |
|
|
|
|